NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions
key details
| Value | £85,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England |
| Deadline | 5 Jan 2017 |
| Contract start | 1 Mar 2017 |
| Contract end | 28 Feb 2018 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-18e546e9-c4ed-4606-9d20-b346eb88b165 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please refer to award schedules for list of awarded suppliers | £0 | 7 Feb 2017 | active |
description
NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions.
Period of framework agreement: 1.3.2017 - 28.2.2018 with an option to extend for up to 12 months.
Additional information: NHS framework agreement for Hepatitis C medicines for Midlands and East and North of England regions
documents
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/34f99ebf-90ba-4801-8202-e6139a87eddd , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/5ec1b073-a16b-4540-8493-231e60a8ed5e , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/d945377f-ccd7-4799-afce-3bdee86a79c5 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Apr 2017 | Award (award) | · | 612700e0-2922-4a41-b871-980c584e703f-143412 |
more from COMMERCIAL MEDICINES UNIT
- NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables · £22,000,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders · £50,600,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products · £4,125,000 · 17 Aug 2018
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- National Framework Agreement for the Supply of Immunoglobulin · £647,709,424 · 27 Mar 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin · £19,539,253 · 23 Dec 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.